Recently Updated Advisory Committee Materials

Recently Updated Advisory Committee Materials

Posted on March 25, 2010

º Oncologic Drugs Advisory Committee

^ 2010 Meeting Materials, Oncologic Drugs Advisory Committee1

^ CGPI Backup Presentation, Omacetaxine (Omapro), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 59.6KB)2 (PDF - 60KB)

^ Final Agenda for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee3 (PDF - 52KB)

^ Final Meeting Roster for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee4 (PDF - 24KB)

^ FDA Core Presentation, Omacetaxine (Omapro), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 553KB)5 (PDF - 554KB)

^ Slides for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee6

^ Final Questions for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee-PM Session-ChemGenex-Omapro7 (PDF - 23KB)

^ FDA Core Presentation, Pixuvri (Pixantrone), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 482KB)8 (PDF - 482KB)

^ CTI Backup Presentation, Pixuvri (Pixantrone), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 1.13MB)9 (PDF - 1167KB)

^ CTI Core Presentation, Pixuvri (Pixantrone), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 720KB)10 (PDF - 721KB)

^ Final Questions for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee-AM Session-Cell Therapeutics-Pixantrone11 (PDF - 59KB)

^ CGPI Core Presentation, Omacetaxine (Omapro), for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee (PDF – 1.01MB)12 (PDF - 1036KB)

and much more to see:
http://www.fda.gov/AdvisoryCommittees/WhatsNew/default.htm